Cipla gets CDSCO panel nod for BE study of idiopathic pulmonary fibrosis drug Pirfenidone Medical Dialogues Team7 Sep 2021 9:29 AM GMTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (C...
Antifibrotic therapy reduces mortality and acute exacerbation in idiopathic pulmonary fibrosis: Chest Dr Satabdi Saha24 July 2021 3:45 AM GMTAntifibrotic treatment appears to reduce the risk of all-cause mortality and acute exacerbation in idiopathic pulmonary fibrosis, according to...
JB Chemicals and Pharmaceuticals launches Nintedanib for treatment in Idiopathic Pulmonary Fibrosis (IPF) Meghna A Singhania26 Jun 2021 5:36 AM GMTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. today announced the launch of 'Nintabid' Capsules containing Nintedanib 100mg and 150mg, an oral...
Usual Care Without Antimicrobials sufficient for Patients with IPF: JAMA MD Bureau29 May 2021 3:30 AM GMTLung dysbiosis, observed as increased bacterial load and/or loss of diversity, has been reported in patients with idiopathic pulmonary fibrosis (IPF). ...
Antimicrobial therapy of not much benefit in idiopathic pulmonary fibrosis: JAMA Medha17 May 2021 4:00 PM GMTUSA: The addition of co-trimoxazole (trimethoprim-sulfamethoxazole) or doxycycline did not significantly improve time to nonrespiratory...
Co-trimoxazole may not improve outcomes of time to death, transplant in IPF: Study Dr. Nandita Mohan11 Dec 2020 1:30 PM GMTResearchers have recently noted that Co-trimoxazole compared with placebo did not improve a composite clinical outcome among patients with moderate...
Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India ruchika21 Oct 2020 7:30 AM GMTNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under th...
BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India ruchika20 Oct 2020 5:36 AM GMTIPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.
Pirfenidone found safe, efficacious in idiopathic pulmonary fibrosis Dr. Kamal Kant Kohli19 May 2020 12:30 PM GMTPirfenidone has been found safe, and efficacious in idiopathic pulmonary fibrosis (IPF) in a real-world cohort study.Pirfenidone is an antifibrotic...
